SKN | Apnimed Raises $192 Million in Upsized IPO as Investors Back Sleep Apnea Drug Candidate
Apnimed, a late-stage biotechnology company developing an oral treatment for obstructive sleep apnea, has priced its initial public offering (IPO) at $16 per share,...
SKN | Churchill Capital Corp XIII Units IPO: Veteran SPAC Sponsor Returns to the Stock Market
Churchill Capital Corp XIII Units is preparing for an initial public offering (IPO), marking the latest special purpose acquisition company (SPAC) sponsored by Churchill...
SKN | Apnimed IPO: Sleep Disorder Drug Developer Targets Public Market to Accelerate Growth
Apnimed, Inc. is preparing for an initial public offering (IPO) as the clinical-stage biopharmaceutical company seeks fresh capital to advance its pipeline of therapies...
SKN | MarketAxess Shares Surge Nearly 30% After Strong Earnings Highlight Electronic Bond Trading Momentum
Shares of MarketAxess Holdings Inc. (NASDAQ: MKTX) surged 29.45% to close at $162.76 on Thursday, before gaining another 0.33% in overnight trading to $163.29....
SKN | Moog Surges Ahead of Earnings as Aerospace and Defense Demand Supports Growth Outlook
Moog Shares Rally Ahead of Quarterly Results
Shares of Moog Inc. (NYSE: MOG-A) climbed 7.54% to close at $419.25 on Thursday, before adding another 0.51%...